Hemgenix is presented ‘conditional authorisation’. Which means that the European Medicines Company resolved that the benefits of Hemgenix are greater than its threats, but the corporate will have to deliver more evidence after authorisation.Based on the clinical experts consulted by CADTH, there are various unmet requires for hemophilia B. Firs… Read More